0.00Open0.01Pre Close0 Volume316 Open Interest900.00Strike Price0.00Turnover3313.19%IV17.63%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0010Delta0.0001Gamma76510.00Leverage Ratio-71.7889Theta0.0000Rho78.75Eff Leverage0.0000Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet